MethADP triammonium

• CAT Number: I041432
• Molecular Formula: C11H26N8O9P2
• Molecular Weight: 476.32
• Purity: ≥95%
• Synonyms: [[(2R,3R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid;azane
• IUPAC Name: triazanium;[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-(phosphonatomethyl)phosphinate
• InChI: InChI=1S/C11H17N5O9P2.3H3N/c12-9-6-10(14-2-13-9)16(3-15-6)11-8(18)7(17)5(25-11)1-24-27(22,23)4-26(19,20)21;;;/h2-3,5,7-8,11,17-18H,1,4H2,(H,22,23)(H2,12,13,14)(H2,19,20,21);3*1H3/t5-,7-,8-,11-;;;/m1.../s1
• InChIKey: YVNOVOOCZCMYRN-MTQUBGKESA-N
• SMILES: C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)([O-])[O-])[O-])O)O)N.[NH4+].[NH4+].[NH4+]

MethADP triammonium（Cat No.:I041432）is a synthetic compound derived from adenosine diphosphate (ADP), incorporating a triammonium group to enhance its solubility and stability. It acts as an intermediate in biochemical processes, particularly in energy metabolism and cellular signaling. MethADP triammonium has potential applications in both pharmaceutical and biochemical research, serving as a useful tool for studying kinase activities, ATP-related signaling pathways, and mitochondrial function. Its role in modulating cellular processes makes it a candidate for exploring treatments in areas such as metabolic diseases and cellular dysfunctions related to neurodegenerative disorders.